Investor Relations
Board of Directors
Biographies of the Bausch & Lomb Board of Directors:
Gerald M. Ostrov, Chairman, Chief Executive Officer
Mr. Ostrov joined Bausch & Lomb in January 2008. From 1998 to 2006, he was company group chairman, Worldwide Vision Care, for Johnson & Johnson, where he led its global Vision Care businesses. Prior, he held other senior leadership roles at Johnson & Johnson, and was president of Ciba Consumer Pharmaceuticals from 1985 to 1991. Mr. Ostrov holds a B.S. degree in industrial engineering and operations research from Cornell University and an M.B.A. from Harvard Business School.
Sean D. Carney, Managing Director, Warburg Pincus
Mr. Carney joined Warburg Pincus in 1996 and focuses on investments in medical devices. Prior to joining Warburg Pincus, he was a consultant with McKinsey & Company. Mr. Carney is a director of Aeolus, Arch Capital Group, DexCom, Keystone Dental, NuLens and Tornier. He received an A.B. degree in economics from Harvard College and an M.B.A. from Harvard Business School.
R. Kerry Clark
Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor’s degree from Queens University.
Joseph P. Landy, Co-President, Warburg Pincus
Mr. Landy joined Warburg Pincus in 1985 and focuses on investments in information technology, communications applications and structured investments. A former president of the Venture Investors Association of New York, Mr. Landy is a trustee of the Clark Art Institute and of the Williamstown Art Conservation Center. He is a director of The Cobalt Group, Telcordia Technologies, RMI Corporation and MicroVest, an investment fund focused on microfinance institutions in developing countries. He holds a B.S. degree in economics from The Wharton School at the University of Pennsylvania and an M.B.A. from the Leonard N. Stern School of Business at New York University.
D. Scott Mackesy, General Partner, Welsh Carson Anderson & Stowe
Mr. Mackesy joined Welsh, Carson, Anderson & Stowe (WCAS) in 1998. He is a general partner focusing on investments in the healthcare industry and is a member of the WCAS Management Committee. Prior, Mr. Mackesy was a senior research analyst at Morgan Stanley Dean Witter, where he was responsible for coverage of the healthcare services sector. Mr. Mackesy serves on the boards of directors of several private companies including Ardent Health Services L.L.C., Renal Advantage, Inc., and United Surgical Partners, Inc.
Robert J. Palmisano, President, Chief Executive Officer, ev3 Inc.
Mr. Palmisano is president, chief executive officer and director of ev3 Inc., a global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3 Inc., Mr. Palmisano was president and chief executive officer for IntraLase Corp. which was later acquired by Advanced Medical Optics Inc. Mr. Palmisano has also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor’s degree from Providence College.
Richard F. Wallman
Mr. Wallman was senior vice president and chief financial officer of Honeywell International, Inc. from 1995 until his retirement in 2003. Prior, he was vice president and controller at IBM Corporation, and held leadership positions at Chrysler Corporation over the course of 14 years. He is a director of Ariba, Convergys, Hayes Lemmerz International, Lear Corporation, and Roper Industries. Mr. Wallman holds a B.S. degree in electrical engineering from Vanderbilt University and an M.B.A. from the University of Chicago.
Elizabeth H. Weatherman, Managing Director, Warburg Pincus
Ms. Weatherman joined Warburg Pincus in 1988 and is responsible for the firm's medical device investment activities. Ms. Weatherman is a director of Bacchus Vascular, ev3 and Tornier. She also serves on the board of the National Venture Capital Association. Ms. Weatherman received a B.A. degree, summa cum laude, from Mount Holyoke College and an M.B.A. from the Stanford Graduate School of Business.
